

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * xenobiotic catabolic process (GO:0042178) | 8.10510057 |
| 2 | * response to nitrosative stress (GO:0051409) | 7.63614600 |
| 3 | gonadal mesoderm development (GO:0007506) | 6.38998580 |
| 4 | glucuronate metabolic process (GO:0019585) | 5.70367710 |
| 5 | uronic acid metabolic process (GO:0006063) | 5.70367710 |
| 6 | cellular glucuronidation (GO:0052695) | 5.50100216 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 5.22629970 |
| 8 | * benzene-containing compound metabolic process (GO:0042537) | 4.57882405 |
| 9 | positive regulation of male gonad development (GO:2000020) | 4.51139036 |
| 10 | androgen biosynthetic process (GO:0006702) | 4.35240667 |
| 11 | regulation of male gonad development (GO:2000018) | 4.31380803 |
| 12 | aggressive behavior (GO:0002118) | 4.20188477 |
| 13 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.20021126 |
| 14 | * glutathione derivative biosynthetic process (GO:1901687) | 4.13699684 |
| 15 | * glutathione derivative metabolic process (GO:1901685) | 4.13699684 |
| 16 | L-ascorbic acid metabolic process (GO:0019852) | 3.93481024 |
| 17 | valine metabolic process (GO:0006573) | 3.89627426 |
| 18 | sex determination (GO:0007530) | 3.77793520 |
| 19 | hormone catabolic process (GO:0042447) | 3.74789634 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 3.66591499 |
| 21 | myofibril assembly (GO:0030239) | 3.63793368 |
| 22 | regulation of female receptivity (GO:0045924) | 3.57464583 |
| 23 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.56492110 |
| 24 | cysteine metabolic process (GO:0006534) | 3.53415256 |
| 25 | negative regulation of protein localization to cell surface (GO:2000009) | 3.45379634 |
| 26 | glyoxylate metabolic process (GO:0046487) | 3.42995937 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42691387 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 3.42691387 |
| 29 | ethanol oxidation (GO:0006069) | 3.42618314 |
| 30 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.41304182 |
| 31 | * glutathione metabolic process (GO:0006749) | 3.40439793 |
| 32 | muscle filament sliding (GO:0030049) | 3.36039529 |
| 33 | actin-myosin filament sliding (GO:0033275) | 3.36039529 |
| 34 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.34272713 |
| 35 | reverse cholesterol transport (GO:0043691) | 3.30357542 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.29662869 |
| 37 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.26014261 |
| 38 | phenylpropanoid metabolic process (GO:0009698) | 3.24667175 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.24508516 |
| 40 | L-phenylalanine metabolic process (GO:0006558) | 3.24508516 |
| 41 | * regulation of skeletal muscle contraction (GO:0014819) | 3.21691425 |
| 42 | regulation of relaxation of muscle (GO:1901077) | 3.19267351 |
| 43 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.18995631 |
| 44 | bile acid biosynthetic process (GO:0006699) | 3.12175419 |
| 45 | positive regulation of vascular permeability (GO:0043117) | 3.11466085 |
| 46 | axoneme assembly (GO:0035082) | 3.08955495 |
| 47 | regulation of phospholipase A2 activity (GO:0032429) | 3.05720215 |
| 48 | homocysteine metabolic process (GO:0050667) | 3.05486663 |
| 49 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.01186948 |
| 50 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.99485150 |
| 51 | one-carbon compound transport (GO:0019755) | 2.98970761 |
| 52 | cardiac myofibril assembly (GO:0055003) | 2.98079570 |
| 53 | skeletal muscle adaptation (GO:0043501) | 2.97160085 |
| 54 | positive regulation of digestive system process (GO:0060456) | 2.96782847 |
| 55 | aromatic amino acid family catabolic process (GO:0009074) | 2.96058900 |
| 56 | metanephric mesenchyme development (GO:0072075) | 2.94720444 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.94347381 |
| 58 | cilium movement (GO:0003341) | 2.94223305 |
| 59 | atrioventricular valve morphogenesis (GO:0003181) | 2.93928296 |
| 60 | neuronal action potential propagation (GO:0019227) | 2.92574586 |
| 61 | regulation of female gonad development (GO:2000194) | 2.92046890 |
| 62 | complement activation, alternative pathway (GO:0006957) | 2.91129445 |
| 63 | renal absorption (GO:0070293) | 2.90773743 |
| 64 | female mating behavior (GO:0060180) | 2.89421781 |
| 65 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.88791915 |
| 66 | protein carboxylation (GO:0018214) | 2.88346603 |
| 67 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88346603 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 2.88243140 |
| 69 | sex differentiation (GO:0007548) | 2.87713826 |
| 70 | definitive hemopoiesis (GO:0060216) | 2.86399517 |
| 71 | epoxygenase P450 pathway (GO:0019373) | 2.86020869 |
| 72 | negative regulation of lipase activity (GO:0060192) | 2.85605127 |
| 73 | positive regulation of p38MAPK cascade (GO:1900745) | 2.85258543 |
| 74 | negative regulation of fatty acid transport (GO:2000192) | 2.85190070 |
| 75 | glomerulus development (GO:0032835) | 2.84516812 |
| 76 | branched-chain amino acid catabolic process (GO:0009083) | 2.84321818 |
| 77 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.83994774 |
| 78 | regulation of cardioblast proliferation (GO:0003264) | 2.83994774 |
| 79 | actin-mediated cell contraction (GO:0070252) | 2.83809998 |
| 80 | regulation of fibrinolysis (GO:0051917) | 2.83359832 |
| 81 | regulation of cholesterol metabolic process (GO:0090181) | 2.82844004 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 2.82398037 |
| 83 | androgen metabolic process (GO:0008209) | 2.81157392 |
| 84 | response to follicle-stimulating hormone (GO:0032354) | 2.81113046 |
| 85 | positive regulation of vasculogenesis (GO:2001214) | 2.79153642 |
| 86 | glomerular basement membrane development (GO:0032836) | 2.75379764 |
| 87 | phospholipid homeostasis (GO:0055091) | 2.74645519 |
| 88 | * xenobiotic metabolic process (GO:0006805) | 2.74604324 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 2.74498165 |
| 90 | fatty acid oxidation (GO:0019395) | 2.73932863 |
| 91 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.73268063 |
| 92 | interkinetic nuclear migration (GO:0022027) | 2.72773197 |
| 93 | negative regulation of fibrinolysis (GO:0051918) | 2.72500747 |
| 94 | urinary tract smooth muscle contraction (GO:0014848) | 2.71867153 |
| 95 | tachykinin receptor signaling pathway (GO:0007217) | 2.71293387 |
| 96 | branched-chain amino acid metabolic process (GO:0009081) | 2.70099823 |
| 97 | drug metabolic process (GO:0017144) | 2.70088005 |
| 98 | regulation of protein activation cascade (GO:2000257) | 2.69463644 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 2.67822840 |
| 100 | tonic smooth muscle contraction (GO:0014820) | 2.67633767 |
| 101 | drug transmembrane transport (GO:0006855) | 2.67617484 |
| 102 | aldehyde catabolic process (GO:0046185) | 2.66778967 |
| 103 | lipid oxidation (GO:0034440) | 2.66153063 |
| 104 | flavonoid metabolic process (GO:0009812) | 2.65373147 |
| 105 | biotin metabolic process (GO:0006768) | 2.64945788 |
| 106 | kynurenine metabolic process (GO:0070189) | 2.64856416 |
| 107 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.63270619 |
| 108 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.62880205 |
| 109 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.62823507 |
| 110 | indole-containing compound catabolic process (GO:0042436) | 2.62687382 |
| 111 | indolalkylamine catabolic process (GO:0046218) | 2.62687382 |
| 112 | tryptophan catabolic process (GO:0006569) | 2.62687382 |
| 113 | creatine metabolic process (GO:0006600) | 2.59547920 |
| 114 | kidney mesenchyme development (GO:0072074) | 2.59523308 |
| 115 | regulation of complement activation (GO:0030449) | 2.59485402 |
| 116 | photoreceptor cell maintenance (GO:0045494) | 2.58828441 |
| 117 | regulation of cholesterol esterification (GO:0010872) | 2.58757510 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 2.57950460 |
| 119 | tryptophan metabolic process (GO:0006568) | 2.57918106 |
| 120 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.57188465 |
| 121 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.57188465 |
| 122 | serine family amino acid catabolic process (GO:0009071) | 2.56377035 |
| 123 | sulfate transmembrane transport (GO:1902358) | 2.55318182 |
| 124 | estrogen metabolic process (GO:0008210) | 2.54228837 |
| 125 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.54129060 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 2.52940583 |
| 127 | bile acid metabolic process (GO:0008206) | 2.52107455 |
| 128 | indolalkylamine metabolic process (GO:0006586) | 2.52067787 |
| 129 | endocardial cushion morphogenesis (GO:0003203) | 2.51900307 |
| 130 | carnitine metabolic process (GO:0009437) | 2.51008904 |
| 131 | fatty acid catabolic process (GO:0009062) | 2.50867807 |
| 132 | response to epinephrine (GO:0071871) | 2.49998653 |
| 133 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.49651518 |
| 134 | epithelial cilium movement (GO:0003351) | 2.48823924 |
| 135 | positive regulation of fatty acid oxidation (GO:0046321) | 2.46455707 |
| 136 | membrane depolarization during action potential (GO:0086010) | 2.46000053 |
| 137 | carnitine transmembrane transport (GO:1902603) | 2.43263957 |
| 138 | * positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.43118385 |
| 139 | cardiolipin metabolic process (GO:0032048) | 2.41115214 |
| 140 | growth hormone receptor signaling pathway (GO:0060396) | 2.41019132 |
| 141 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.40656232 |
| 142 | striated muscle atrophy (GO:0014891) | 2.39209578 |
| 143 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.37895602 |
| 144 | quaternary ammonium group transport (GO:0015697) | 2.34011152 |
| 145 | drinking behavior (GO:0042756) | 2.33863872 |
| 146 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.33048219 |
| 147 | auditory receptor cell stereocilium organization (GO:0060088) | 2.32990106 |
| 148 | negative regulation of complement activation (GO:0045916) | 2.31587243 |
| 149 | fatty acid transmembrane transport (GO:1902001) | 2.31565976 |
| 150 | amino-acid betaine transport (GO:0015838) | 2.30939275 |
| 151 | carnitine transport (GO:0015879) | 2.30939275 |
| 152 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.30234269 |
| 153 | NAD biosynthetic process (GO:0009435) | 2.27499067 |
| 154 | neurotransmitter catabolic process (GO:0042135) | 2.25076620 |
| 155 | regulation of vasculogenesis (GO:2001212) | 2.23977685 |
| 156 | regulation of cell communication by electrical coupling (GO:0010649) | 2.23616012 |
| 157 | cellular ketone body metabolic process (GO:0046950) | 2.22983592 |
| 158 | dermatan sulfate metabolic process (GO:0030205) | 2.22274434 |
| 159 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.21563321 |
| 160 | * regulation of striated muscle contraction (GO:0006942) | 2.20349852 |
| 161 | regulation of protein glycosylation (GO:0060049) | 2.19953165 |
| 162 | cellular response to sterol (GO:0036315) | 2.18983377 |
| 163 | skeletal muscle contraction (GO:0003009) | 2.18331663 |
| 164 | cellular response to epinephrine stimulus (GO:0071872) | 2.18040115 |
| 165 | striated muscle contraction (GO:0006941) | 2.17844268 |
| 166 | * positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.16360060 |
| 167 | cellular response to growth hormone stimulus (GO:0071378) | 2.15742391 |
| 168 | myotube cell development (GO:0014904) | 2.14573667 |
| 169 | negative regulation of humoral immune response (GO:0002921) | 2.14032324 |
| 170 | regulation of actin filament-based movement (GO:1903115) | 2.11486520 |
| 171 | cGMP metabolic process (GO:0046068) | 2.10957729 |
| 172 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.10686365 |
| 173 | negative regulation of B cell mediated immunity (GO:0002713) | 2.10686365 |
| 174 | behavioral response to ethanol (GO:0048149) | 2.10303647 |
| 175 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.09095298 |
| 176 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.09005490 |
| 177 | regulation of sarcomere organization (GO:0060297) | 2.08557936 |
| 178 | * regulation of calcium ion transmembrane transport (GO:1903169) | 2.08080347 |
| 179 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.08080347 |
| 180 | actin filament-based movement (GO:0030048) | 2.07946907 |
| 181 | motile cilium assembly (GO:0044458) | 2.07375994 |
| 182 | muscle contraction (GO:0006936) | 2.06346232 |
| 183 | response to misfolded protein (GO:0051788) | 2.06304507 |
| 184 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.05856994 |
| 185 | skeletal muscle tissue regeneration (GO:0043403) | 2.02706275 |
| 186 | striated muscle adaptation (GO:0014888) | 2.02345982 |
| 187 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.01244487 |
| 188 | negative regulation of protein activation cascade (GO:2000258) | 2.01001065 |
| 189 | postsynaptic membrane organization (GO:0001941) | 2.00981403 |
| 190 | hyperosmotic salinity response (GO:0042538) | 1.99915991 |
| 191 | tyrosine phosphorylation of STAT protein (GO:0007260) | 1.99051139 |
| 192 | regulation of sequestering of triglyceride (GO:0010889) | 1.97975889 |
| 193 | cGMP-mediated signaling (GO:0019934) | 1.96849291 |
| 194 | muscle fiber development (GO:0048747) | 1.96767320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.28396322 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.52817138 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.52770869 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.06911918 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.04332461 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.02424940 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.89304557 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.82167491 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.72841872 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.21856886 |
| 11 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.07318816 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.03946567 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.01131721 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.00481680 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.96271496 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.63497635 |
| 17 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.63128186 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36239300 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.33934354 |
| 20 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.22877446 |
| 21 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.22877446 |
| 22 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.22877446 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14992452 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.10683432 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09578354 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03205275 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.98790829 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93158177 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.84757101 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83500616 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77752341 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76978473 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.75960131 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75533600 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68706973 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66902443 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66022820 |
| 38 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.64621843 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63754725 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62613814 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62585921 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59896036 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55728575 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53954544 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52941895 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52468810 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.49334724 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49100112 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45602782 |
| 50 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44686672 |
| 51 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44607881 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43614438 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.42732433 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42162952 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41556357 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41547420 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41463460 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41322944 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41013675 |
| 60 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40708234 |
| 61 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40708234 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40321677 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39387608 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38479310 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35804085 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32926775 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32583679 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.32211501 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.31687234 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30613883 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30515505 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29892101 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26084777 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23099221 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22796141 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22755351 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22452911 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22218788 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20621938 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20519937 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20406737 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19891937 |
| 83 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18666933 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17995973 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17995973 |
| 86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.17848844 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17531126 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15288769 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14974544 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14974544 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14779856 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14753605 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14224868 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14162190 |
| 95 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12594440 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11626069 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11470532 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.11453842 |
| 99 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.11230342 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11022423 |
| 101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10265777 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09974880 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09281089 |
| 104 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08456196 |
| 105 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07644743 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07177823 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06828915 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06826603 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06754609 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06522326 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06464346 |
| 112 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06198336 |
| 113 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06078200 |
| 114 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05746695 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05102367 |
| 116 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04973391 |
| 117 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04876046 |
| 118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04720665 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04548639 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04075936 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03889112 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03889112 |
| 123 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03811347 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03147712 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02956678 |
| 126 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02823964 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02823964 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02536356 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01696887 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01334666 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00388994 |
| 132 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.99512609 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99252079 |
| 134 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.99027426 |
| 135 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98972533 |
| 136 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98404133 |
| 137 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98140055 |
| 138 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97885780 |
| 139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97484630 |
| 140 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97453998 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96602023 |
| 142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96309842 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95210397 |
| 144 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95022488 |
| 145 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94550921 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94108652 |
| 147 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93531802 |
| 148 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93450642 |
| 149 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92879805 |
| 150 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92734055 |
| 151 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92489158 |
| 152 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92194406 |
| 153 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92016937 |
| 154 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91902878 |
| 155 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91780565 |
| 156 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91317728 |
| 157 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90980906 |
| 158 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90962266 |
| 159 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90207981 |
| 160 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90038931 |
| 161 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89970196 |
| 162 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89942870 |
| 163 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89869973 |
| 164 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89552151 |
| 165 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89262081 |
| 166 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89204178 |
| 167 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89136257 |
| 168 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88961269 |
| 169 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88715494 |
| 170 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87546873 |
| 171 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86773029 |
| 172 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85342745 |
| 173 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.85170478 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84143477 |
| 175 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83335964 |
| 176 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82429255 |
| 177 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82107874 |
| 178 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82096281 |
| 179 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81361561 |
| 180 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77274605 |
| 181 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75033449 |
| 182 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74987260 |
| 183 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.74237712 |
| 184 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72093048 |
| 185 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71905554 |
| 186 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71408370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00962148 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.17335641 |
| 3 | MP0005365_abnormal_bile_salt | 3.76838812 |
| 4 | MP0003646_muscle_fatigue | 3.53455402 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 3.30768128 |
| 6 | MP0000751_myopathy | 3.18189141 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.17362259 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.01508653 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.99171373 |
| 10 | MP0008995_early_reproductive_senescence | 2.88501953 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.84741571 |
| 12 | MP0005360_urolithiasis | 2.67141686 |
| 13 | MP0003195_calcinosis | 2.64136874 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.44807509 |
| 15 | MP0000749_muscle_degeneration | 2.37897165 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 2.37806197 |
| 17 | MP0010030_abnormal_orbit_morphology | 2.29768304 |
| 18 | MP0004130_abnormal_muscle_cell | 2.24221855 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.15879164 |
| 20 | MP0003186_abnormal_redox_activity | 2.14239737 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.98016189 |
| 22 | MP0009384_cardiac_valve_regurgitation | 1.97852923 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.95615290 |
| 24 | MP0005499_abnormal_olfactory_system | 1.94546468 |
| 25 | MP0005394_taste/olfaction_phenotype | 1.94546468 |
| 26 | MP0005275_abnormal_skin_tensile | 1.89571668 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 1.89361793 |
| 28 | MP0003878_abnormal_ear_physiology | 1.89361793 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.88364862 |
| 30 | MP0002108_abnormal_muscle_morphology | 1.87431992 |
| 31 | MP0002254_reproductive_system_inflammat | 1.85639446 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.80903675 |
| 33 | MP0003252_abnormal_bile_duct | 1.80543374 |
| 34 | MP0005083_abnormal_biliary_tract | 1.77913709 |
| 35 | MP0003279_aneurysm | 1.75419041 |
| 36 | MP0005620_abnormal_muscle_contractility | 1.69889929 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.69469831 |
| 38 | MP0005647_abnormal_sex_gland | 1.69015180 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.68988739 |
| 40 | MP0001958_emphysema | 1.68593172 |
| 41 | MP0005408_hypopigmentation | 1.67718124 |
| 42 | MP0004272_abnormal_basement_membrane | 1.64769961 |
| 43 | MP0001984_abnormal_olfaction | 1.64206898 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.61702185 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.61684552 |
| 46 | MP0005369_muscle_phenotype | 1.60234891 |
| 47 | MP0002735_abnormal_chemical_nociception | 1.60076103 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.57761339 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.56772859 |
| 50 | MP0009053_abnormal_anal_canal | 1.56230320 |
| 51 | MP0004043_abnormal_pH_regulation | 1.55448754 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.54836368 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.54797166 |
| 54 | MP0001486_abnormal_startle_reflex | 1.50281007 |
| 55 | MP0005332_abnormal_amino_acid | 1.50267131 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.47736093 |
| 57 | MP0003045_fibrosis | 1.47517522 |
| 58 | MP0002295_abnormal_pulmonary_circulatio | 1.46826429 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.43148704 |
| 60 | MP0004484_altered_response_of | 1.42353720 |
| 61 | MP0002971_abnormal_brown_adipose | 1.41084338 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.36441532 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.35237045 |
| 64 | MP0003137_abnormal_impulse_conducting | 1.34271513 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.33414377 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.32593916 |
| 67 | MP0005670_abnormal_white_adipose | 1.32310715 |
| 68 | MP0005503_abnormal_tendon_morphology | 1.31334064 |
| 69 | MP0000230_abnormal_systemic_arterial | 1.29854161 |
| 70 | MP0001970_abnormal_pain_threshold | 1.25335013 |
| 71 | MP0002736_abnormal_nociception_after | 1.23415170 |
| 72 | MP0004087_abnormal_muscle_fiber | 1.21348143 |
| 73 | MP0000759_abnormal_skeletal_muscle | 1.20357773 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.19774970 |
| 75 | MP0004859_abnormal_synaptic_plasticity | 1.19755709 |
| 76 | MP0005535_abnormal_body_temperature | 1.19506416 |
| 77 | MP0002060_abnormal_skin_morphology | 1.19347305 |
| 78 | MP0008004_abnormal_stomach_pH | 1.18255400 |
| 79 | MP0006054_spinal_hemorrhage | 1.17410013 |
| 80 | MP0009745_abnormal_behavioral_response | 1.17290597 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 1.15154481 |
| 82 | MP0003879_abnormal_hair_cell | 1.14951705 |
| 83 | MP0004085_abnormal_heartbeat | 1.13757897 |
| 84 | MP0000762_abnormal_tongue_morphology | 1.13470114 |
| 85 | MP0002132_abnormal_respiratory_system | 1.13228957 |
| 86 | MP0003786_premature_aging | 1.12804439 |
| 87 | MP0002733_abnormal_thermal_nociception | 1.12569011 |
| 88 | MP0002933_joint_inflammation | 1.11929939 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 1.09800084 |
| 90 | MP0000678_abnormal_parathyroid_gland | 1.09343595 |
| 91 | MP0002572_abnormal_emotion/affect_behav | 1.08715942 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 1.07958822 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 1.07747347 |
| 94 | MP0000516_abnormal_urinary_system | 1.07747347 |
| 95 | MP0003942_abnormal_urinary_system | 1.07670313 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 1.07255911 |
| 97 | MP0009278_abnormal_bone_marrow | 1.07109073 |
| 98 | MP0002972_abnormal_cardiac_muscle | 1.06627884 |
| 99 | MP0002332_abnormal_exercise_endurance | 1.05584577 |
| 100 | MP0000537_abnormal_urethra_morphology | 1.05251894 |
| 101 | MP0001756_abnormal_urination | 1.05074935 |
| 102 | MP0002233_abnormal_nose_morphology | 1.04820105 |
| 103 | MP0009046_muscle_twitch | 1.04334514 |
| 104 | MP0003566_abnormal_cell_adhesion | 1.03900570 |
| 105 | MP0008569_lethality_at_weaning | 1.03196530 |
| 106 | MP0000534_abnormal_ureter_morphology | 1.03070283 |
| 107 | MP0005248_abnormal_Harderian_gland | 1.02930947 |
| 108 | MP0006138_congestive_heart_failure | 1.02834850 |
| 109 | MP0003191_abnormal_cellular_cholesterol | 1.02106848 |
| 110 | MP0002272_abnormal_nervous_system | 1.00796713 |
| 111 | MP0002269_muscular_atrophy | 1.00058030 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.99244245 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.99244245 |
| 114 | MP0002734_abnormal_mechanical_nocicepti | 0.98852590 |
| 115 | MP0003635_abnormal_synaptic_transmissio | 0.97026866 |
| 116 | MP0001664_abnormal_digestion | 0.96331371 |
| 117 | MP0005023_abnormal_wound_healing | 0.95691836 |
| 118 | MP0003115_abnormal_respiratory_system | 0.95103634 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.94964585 |
| 120 | MP0009840_abnormal_foam_cell | 0.94760531 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.94590827 |
| 122 | MP0000609_abnormal_liver_physiology | 0.93890281 |
| 123 | MP0005171_absent_coat_pigmentation | 0.93545142 |
| 124 | MP0003633_abnormal_nervous_system | 0.93477330 |
| 125 | MP0002168_other_aberrant_phenotype | 0.91991836 |
| 126 | MP0004142_abnormal_muscle_tone | 0.91313849 |
| 127 | MP0002064_seizures | 0.90793542 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.89819131 |
| 129 | MP0000747_muscle_weakness | 0.89547487 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.88219887 |
| 131 | MP0001346_abnormal_lacrimal_gland | 0.87251870 |
| 132 | MP0002067_abnormal_sensory_capabilities | 0.84913086 |
| 133 | MP0001661_extended_life_span | 0.83781671 |
| 134 | MP0003828_pulmonary_edema | 0.83529831 |
| 135 | MP0002249_abnormal_larynx_morphology | 0.83317388 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.81916163 |
| 137 | MP0003936_abnormal_reproductive_system | 0.81276339 |
| 138 | MP0004883_abnormal_blood_vessel | 0.80745915 |
| 139 | MP0003136_yellow_coat_color | 0.80091649 |
| 140 | MP0005164_abnormal_response_to | 0.77836280 |
| 141 | MP0004147_increased_porphyrin_level | 0.76586357 |
| 142 | MP0001963_abnormal_hearing_physiology | 0.76547236 |
| 143 | MP0001879_abnormal_lymphatic_vessel | 0.76448968 |
| 144 | MP0005253_abnormal_eye_physiology | 0.76102839 |
| 145 | MP0000613_abnormal_salivary_gland | 0.75786563 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.75613160 |
| 147 | MP0003941_abnormal_skin_development | 0.74872358 |
| 148 | MP0003724_increased_susceptibility_to | 0.73746858 |
| 149 | MP0003950_abnormal_plasma_membrane | 0.73451721 |
| 150 | MP0001919_abnormal_reproductive_system | 0.73076023 |
| 151 | MP0002102_abnormal_ear_morphology | 0.72848668 |
| 152 | MP0005508_abnormal_skeleton_morphology | 0.70709485 |
| 153 | MP0000767_abnormal_smooth_muscle | 0.70636006 |
| 154 | MP0002837_dystrophic_cardiac_calcinosis | 0.70475481 |
| 155 | MP0003690_abnormal_glial_cell | 0.70250799 |
| 156 | MP0010630_abnormal_cardiac_muscle | 0.69828537 |
| 157 | MP0004084_abnormal_cardiac_muscle | 0.68383957 |
| 158 | MP0005084_abnormal_gallbladder_morpholo | 0.67802319 |
| 159 | MP0002160_abnormal_reproductive_system | 0.67296471 |
| 160 | MP0005389_reproductive_system_phenotype | 0.66035834 |
| 161 | MP0003315_abnormal_perineum_morphology | 0.65794392 |
| 162 | MP0008872_abnormal_physiological_respon | 0.65244885 |
| 163 | MP0002009_preneoplasia | 0.63790063 |
| 164 | MP0005330_cardiomyopathy | 0.63349956 |
| 165 | MP0005220_abnormal_exocrine_pancreas | 0.62830898 |
| 166 | MP0000049_abnormal_middle_ear | 0.62730424 |
| 167 | MP0005666_abnormal_adipose_tissue | 0.62542449 |
| 168 | MP0004782_abnormal_surfactant_physiolog | 0.61746914 |
| 169 | MP0002133_abnormal_respiratory_system | 0.61448291 |
| 170 | MP0005388_respiratory_system_phenotype | 0.61448291 |
| 171 | MP0003300_gastrointestinal_ulcer | 0.61362946 |
| 172 | MP0005385_cardiovascular_system_phenoty | 0.59599882 |
| 173 | MP0001544_abnormal_cardiovascular_syste | 0.59599882 |
| 174 | MP0003453_abnormal_keratinocyte_physiol | 0.59256797 |
| 175 | MP0000598_abnormal_liver_morphology | 0.58826366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.20903004 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 4.35938272 |
| 3 | Gonadal dysgenesis (HP:0000133) | 4.13576915 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.11804280 |
| 5 | Nemaline bodies (HP:0003798) | 4.11660689 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.94014213 |
| 7 | Deep venous thrombosis (HP:0002625) | 3.67861667 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.64659521 |
| 9 | Distal arthrogryposis (HP:0005684) | 3.64600662 |
| 10 | Male infertility (HP:0003251) | 3.49602045 |
| 11 | Male pseudohermaphroditism (HP:0000037) | 3.43311953 |
| 12 | Abnormal hemoglobin (HP:0011902) | 3.41418059 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.40997162 |
| 14 | Protrusio acetabuli (HP:0003179) | 3.39844554 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.36639551 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.31284808 |
| 17 | Genetic anticipation (HP:0003743) | 3.22952341 |
| 18 | Myoglobinuria (HP:0002913) | 3.19120511 |
| 19 | Fat malabsorption (HP:0002630) | 3.15256296 |
| 20 | Steatorrhea (HP:0002570) | 3.08588296 |
| 21 | Gonadotropin excess (HP:0000837) | 3.06827764 |
| 22 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.02507498 |
| 23 | Absent/shortened dynein arms (HP:0200106) | 3.02507498 |
| 24 | Abnormal ciliary motility (HP:0012262) | 3.01010463 |
| 25 | Xanthomatosis (HP:0000991) | 2.97614999 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 2.92435803 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.91207588 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 2.87962467 |
| 29 | Abnormality of the calf musculature (HP:0001430) | 2.85017716 |
| 30 | Complement deficiency (HP:0004431) | 2.82811811 |
| 31 | True hermaphroditism (HP:0010459) | 2.81461697 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.81159270 |
| 33 | Round ear (HP:0100830) | 2.81098265 |
| 34 | Areflexia of lower limbs (HP:0002522) | 2.80623309 |
| 35 | Diplopia (HP:0000651) | 2.78984534 |
| 36 | Abnormality of binocular vision (HP:0011514) | 2.78984534 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.78776380 |
| 38 | Pancreatic fibrosis (HP:0100732) | 2.76035180 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 2.74466605 |
| 40 | Pancreatic cysts (HP:0001737) | 2.72523782 |
| 41 | Hyperglycinuria (HP:0003108) | 2.72430857 |
| 42 | Hyperkalemia (HP:0002153) | 2.68841679 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.66714265 |
| 44 | Increased connective tissue (HP:0009025) | 2.64779019 |
| 45 | Hypoplasia of the uterus (HP:0000013) | 2.62736046 |
| 46 | Febrile seizures (HP:0002373) | 2.62497178 |
| 47 | Clumsiness (HP:0002312) | 2.61780131 |
| 48 | Cystic liver disease (HP:0006706) | 2.58591406 |
| 49 | Bifid scrotum (HP:0000048) | 2.56606366 |
| 50 | Fragile skin (HP:0001030) | 2.56323366 |
| 51 | Sex reversal (HP:0012245) | 2.54442483 |
| 52 | Abnormal sex determination (HP:0012244) | 2.54442483 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54321947 |
| 54 | Ankle contracture (HP:0006466) | 2.53248428 |
| 55 | Aortic aneurysm (HP:0004942) | 2.53222610 |
| 56 | Lip pit (HP:0100267) | 2.51862545 |
| 57 | Testicular neoplasm (HP:0010788) | 2.51677207 |
| 58 | Stomach cancer (HP:0012126) | 2.51527224 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.47927562 |
| 60 | Pulmonary artery stenosis (HP:0004415) | 2.47272267 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.47223873 |
| 62 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.46885623 |
| 63 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.46296919 |
| 64 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.45909421 |
| 65 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.45909421 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45882761 |
| 67 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.45608464 |
| 68 | Hyperammonemia (HP:0001987) | 2.44267436 |
| 69 | Follicular hyperkeratosis (HP:0007502) | 2.44176121 |
| 70 | Papilledema (HP:0001085) | 2.44076957 |
| 71 | Sudden death (HP:0001699) | 2.42514795 |
| 72 | Nausea (HP:0002018) | 2.41919047 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41661952 |
| 74 | Osteolytic defects of the hand bones (HP:0009699) | 2.41661952 |
| 75 | Myocardial infarction (HP:0001658) | 2.40591425 |
| 76 | Ketosis (HP:0001946) | 2.38500437 |
| 77 | Hypolipoproteinemia (HP:0010981) | 2.37712061 |
| 78 | Abnormality of the renal medulla (HP:0100957) | 2.34759732 |
| 79 | Nephronophthisis (HP:0000090) | 2.34748573 |
| 80 | Asymmetric septal hypertrophy (HP:0001670) | 2.33923254 |
| 81 | Azoospermia (HP:0000027) | 2.33867097 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 2.33374489 |
| 83 | Bundle branch block (HP:0011710) | 2.33234355 |
| 84 | Abnormal cartilage morphology (HP:0002763) | 2.31865476 |
| 85 | Hypoglycemic coma (HP:0001325) | 2.29749354 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.29271766 |
| 87 | Myotonia (HP:0002486) | 2.28882026 |
| 88 | Hyperventilation (HP:0002883) | 2.28055125 |
| 89 | Difficulty running (HP:0009046) | 2.27499166 |
| 90 | Abnormality of the ischium (HP:0003174) | 2.26655047 |
| 91 | Preauricular pit (HP:0004467) | 2.26363147 |
| 92 | Periauricular skin pits (HP:0100277) | 2.26363147 |
| 93 | EMG: myopathic abnormalities (HP:0003458) | 2.25865154 |
| 94 | Congenital hepatic fibrosis (HP:0002612) | 2.25573304 |
| 95 | Focal motor seizures (HP:0011153) | 2.25531440 |
| 96 | Hypoplastic ischia (HP:0003175) | 2.24761817 |
| 97 | Focal seizures (HP:0007359) | 2.24482429 |
| 98 | Epidermoid cyst (HP:0200040) | 2.24022510 |
| 99 | Alopecia of scalp (HP:0002293) | 2.22899794 |
| 100 | Steppage gait (HP:0003376) | 2.22797146 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.22663875 |
| 102 | Ketoacidosis (HP:0001993) | 2.22609530 |
| 103 | Neck muscle weakness (HP:0000467) | 2.21369809 |
| 104 | Abnormality of complement system (HP:0005339) | 2.20609306 |
| 105 | Mesangial abnormality (HP:0001966) | 2.19937205 |
| 106 | Facial diplegia (HP:0001349) | 2.19888041 |
| 107 | Hypobetalipoproteinemia (HP:0003563) | 2.19118761 |
| 108 | Ulnar deviation of the wrist (HP:0003049) | 2.18652823 |
| 109 | Polycythemia (HP:0001901) | 2.18621806 |
| 110 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.18364034 |
| 111 | EMG: neuropathic changes (HP:0003445) | 2.18356447 |
| 112 | Abnormal drinking behavior (HP:0030082) | 2.16403619 |
| 113 | Polydipsia (HP:0001959) | 2.16403619 |
| 114 | Hepatocellular carcinoma (HP:0001402) | 2.16090856 |
| 115 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15980178 |
| 116 | Decreased circulating renin level (HP:0003351) | 2.14588823 |
| 117 | Abnormality of glycine metabolism (HP:0010895) | 2.14564309 |
| 118 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14564309 |
| 119 | Absent phalangeal crease (HP:0006109) | 2.14211727 |
| 120 | Central scotoma (HP:0000603) | 2.12699669 |
| 121 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.11212628 |
| 122 | Renal tubular acidosis (HP:0001947) | 2.10901391 |
| 123 | Attenuation of retinal blood vessels (HP:0007843) | 2.10416391 |
| 124 | Abnormality of the renal cortex (HP:0011035) | 2.10343648 |
| 125 | Hyperlipoproteinemia (HP:0010980) | 2.09207996 |
| 126 | Palpitations (HP:0001962) | 2.08458842 |
| 127 | Prolonged QT interval (HP:0001657) | 2.08191902 |
| 128 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07872720 |
| 129 | Abnormality of male internal genitalia (HP:0000022) | 2.07382430 |
| 130 | Proximal tubulopathy (HP:0000114) | 2.06602436 |
| 131 | Hip contracture (HP:0003273) | 2.06424201 |
| 132 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.05970166 |
| 133 | Congenital stationary night blindness (HP:0007642) | 2.05125004 |
| 134 | Vascular calcification (HP:0004934) | 2.03054462 |
| 135 | Stridor (HP:0010307) | 2.02449093 |
| 136 | Abnormality of potassium homeostasis (HP:0011042) | 2.01540527 |
| 137 | Chronic hepatic failure (HP:0100626) | 2.01214479 |
| 138 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98363944 |
| 139 | Bell-shaped thorax (HP:0001591) | 1.97881878 |
| 140 | Medial flaring of the eyebrow (HP:0010747) | 1.97602087 |
| 141 | Short hallux (HP:0010109) | 1.97462417 |
| 142 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96832708 |
| 143 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.96567928 |
| 144 | Syncope (HP:0001279) | 1.96428674 |
| 145 | Postural instability (HP:0002172) | 1.96104052 |
| 146 | Spinal rigidity (HP:0003306) | 1.95831187 |
| 147 | Gait imbalance (HP:0002141) | 1.95761909 |
| 148 | Humeroradial synostosis (HP:0003041) | 1.95232380 |
| 149 | Synostosis involving the elbow (HP:0003938) | 1.95232380 |
| 150 | Short nail (HP:0001799) | 1.94922197 |
| 151 | Hyporeflexia of lower limbs (HP:0002600) | 1.94755368 |
| 152 | Hypoplasia of the iris (HP:0007676) | 1.94522284 |
| 153 | Esophageal varix (HP:0002040) | 1.94502530 |
| 154 | Lymphangioma (HP:0100764) | 1.94344706 |
| 155 | Type 1 muscle fiber predominance (HP:0003803) | 1.94281201 |
| 156 | Difficulty walking (HP:0002355) | 1.94038725 |
| 157 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.93949729 |
| 158 | Atonic seizures (HP:0010819) | 1.93803638 |
| 159 | Neoplasm of the heart (HP:0100544) | 1.93694366 |
| 160 | Aortic dissection (HP:0002647) | 1.93350205 |
| 161 | Hypoplastic left heart (HP:0004383) | 1.93244303 |
| 162 | Atrophic scars (HP:0001075) | 1.92247860 |
| 163 | Redundant skin (HP:0001582) | 1.91763103 |
| 164 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91359314 |
| 165 | Cerebral palsy (HP:0100021) | 1.90624821 |
| 166 | Hypokalemia (HP:0002900) | 1.89882224 |
| 167 | Atrial fibrillation (HP:0005110) | 1.89258585 |
| 168 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.88231019 |
| 169 | Systemic lupus erythematosus (HP:0002725) | 1.87893477 |
| 170 | Hyperglycinemia (HP:0002154) | 1.87425380 |
| 171 | Rectal prolapse (HP:0002035) | 1.87156639 |
| 172 | Heart block (HP:0012722) | 1.86554223 |
| 173 | Joint hemorrhage (HP:0005261) | 1.85073598 |
| 174 | Congenital primary aphakia (HP:0007707) | 1.84874820 |
| 175 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.84397194 |
| 176 | Dialeptic seizures (HP:0011146) | 1.84150040 |
| 177 | Absent speech (HP:0001344) | 1.84038703 |
| 178 | Absence seizures (HP:0002121) | 1.83398709 |
| 179 | Limited hip movement (HP:0008800) | 1.83304046 |
| 180 | Abnormality of midbrain morphology (HP:0002418) | 1.83217367 |
| 181 | Molar tooth sign on MRI (HP:0002419) | 1.83217367 |
| 182 | Rickets (HP:0002748) | 1.82922223 |
| 183 | Bile duct proliferation (HP:0001408) | 1.80629601 |
| 184 | Abnormal biliary tract physiology (HP:0012439) | 1.80629601 |
| 185 | Nephritis (HP:0000123) | 1.80619037 |
| 186 | Hypercholesterolemia (HP:0003124) | 1.80286320 |
| 187 | Alveolar cell carcinoma (HP:0006519) | 1.79303362 |
| 188 | Ventricular tachycardia (HP:0004756) | 1.79295824 |
| 189 | Hemiparesis (HP:0001269) | 1.78589566 |
| 190 | Gowers sign (HP:0003391) | 1.78562157 |
| 191 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.77435391 |
| 192 | Subaortic stenosis (HP:0001682) | 1.77435391 |
| 193 | Bronchomalacia (HP:0002780) | 1.77340452 |
| 194 | Mitral stenosis (HP:0001718) | 1.77011720 |
| 195 | Broad metatarsal (HP:0001783) | 1.76764464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.86254846 |
| 2 | OBSCN | 3.71142086 |
| 3 | ERN1 | 3.29385541 |
| 4 | RIPK1 | 3.28028322 |
| 5 | MYLK | 3.06159706 |
| 6 | MAP3K3 | 2.89188855 |
| 7 | TAOK3 | 2.81099319 |
| 8 | TRIB3 | 2.60293258 |
| 9 | LATS1 | 2.48491457 |
| 10 | MAP3K7 | 2.35361040 |
| 11 | EPHB2 | 2.32194079 |
| 12 | ZAK | 2.25462497 |
| 13 | TESK1 | 2.23333830 |
| 14 | PHKG1 | 2.06796087 |
| 15 | PHKG2 | 2.06796087 |
| 16 | TTN | 1.99333824 |
| 17 | MAP2K2 | 1.93040659 |
| 18 | STK38L | 1.78521676 |
| 19 | SIK1 | 1.75769803 |
| 20 | PTK6 | 1.75507751 |
| 21 | PKN2 | 1.71774262 |
| 22 | FRK | 1.62511759 |
| 23 | KIT | 1.61076139 |
| 24 | FER | 1.60116732 |
| 25 | EPHB1 | 1.58219514 |
| 26 | MAP2K3 | 1.57582756 |
| 27 | MAPK15 | 1.50460311 |
| 28 | BMPR1B | 1.48688725 |
| 29 | RPS6KB2 | 1.45412286 |
| 30 | NTRK3 | 1.45223666 |
| 31 | EPHA3 | 1.41642370 |
| 32 | MAP3K2 | 1.34798709 |
| 33 | MAPK13 | 1.34121378 |
| 34 | PDGFRA | 1.33640315 |
| 35 | DAPK2 | 1.32364485 |
| 36 | FES | 1.31894405 |
| 37 | ACVR1B | 1.29404568 |
| 38 | PDK2 | 1.28402042 |
| 39 | MAPKAPK3 | 1.28398238 |
| 40 | LMTK2 | 1.28021174 |
| 41 | FGFR4 | 1.27698354 |
| 42 | MAP4K1 | 1.23016424 |
| 43 | MAP4K2 | 1.18353054 |
| 44 | RPS6KA4 | 1.16353847 |
| 45 | PRKAA2 | 1.13523729 |
| 46 | PDK3 | 1.11941682 |
| 47 | PDK4 | 1.11941682 |
| 48 | WNK3 | 1.11332233 |
| 49 | DMPK | 1.11089996 |
| 50 | ADRBK2 | 1.10320084 |
| 51 | NUAK1 | 1.09638983 |
| 52 | LIMK1 | 1.09256649 |
| 53 | MST1R | 1.08599628 |
| 54 | CAMK1 | 1.07463759 |
| 55 | STK38 | 1.05833521 |
| 56 | TYRO3 | 1.05684715 |
| 57 | MAPK12 | 1.05461929 |
| 58 | LATS2 | 1.03668129 |
| 59 | PAK3 | 1.02792753 |
| 60 | PBK | 1.01606472 |
| 61 | MET | 0.97275350 |
| 62 | ADRBK1 | 0.96176003 |
| 63 | AKT3 | 0.95818697 |
| 64 | PKN1 | 0.92551061 |
| 65 | NEK9 | 0.91695162 |
| 66 | EPHA2 | 0.91324724 |
| 67 | MAP2K1 | 0.90120200 |
| 68 | STK3 | 0.87922934 |
| 69 | MAP2K6 | 0.87771575 |
| 70 | PTK2B | 0.87466077 |
| 71 | GRK5 | 0.87098184 |
| 72 | MARK2 | 0.86203050 |
| 73 | TEC | 0.85267035 |
| 74 | INSRR | 0.85085644 |
| 75 | MUSK | 0.84244254 |
| 76 | ERBB2 | 0.83856889 |
| 77 | MAP3K11 | 0.83648810 |
| 78 | TAOK2 | 0.81484020 |
| 79 | ERBB4 | 0.80769448 |
| 80 | GSK3A | 0.79817936 |
| 81 | SGK3 | 0.79514201 |
| 82 | FGFR2 | 0.78352738 |
| 83 | PAK2 | 0.77395451 |
| 84 | MARK1 | 0.77292497 |
| 85 | CAMK1D | 0.77012689 |
| 86 | ERBB3 | 0.76789161 |
| 87 | EPHA4 | 0.76565404 |
| 88 | MST4 | 0.75614629 |
| 89 | DDR2 | 0.73798392 |
| 90 | BTK | 0.73398922 |
| 91 | DYRK1A | 0.73097186 |
| 92 | CHUK | 0.72625683 |
| 93 | NME1 | 0.71863566 |
| 94 | ROCK1 | 0.71461676 |
| 95 | SGK2 | 0.71351576 |
| 96 | GRK1 | 0.71269502 |
| 97 | CDK6 | 0.70630092 |
| 98 | STK4 | 0.69783234 |
| 99 | PIK3CA | 0.69305862 |
| 100 | TIE1 | 0.69300385 |
| 101 | FLT3 | 0.68787070 |
| 102 | MAP3K6 | 0.68723117 |
| 103 | PRKAA1 | 0.68108134 |
| 104 | NLK | 0.67989969 |
| 105 | NTRK2 | 0.67450986 |
| 106 | PRKD2 | 0.66961973 |
| 107 | CDC42BPA | 0.66640017 |
| 108 | PTK2 | 0.66287499 |
| 109 | PAK4 | 0.64656376 |
| 110 | PINK1 | 0.63131461 |
| 111 | PIK3CG | 0.62937694 |
| 112 | HCK | 0.62143735 |
| 113 | PRKD3 | 0.62134440 |
| 114 | MAPK7 | 0.61151491 |
| 115 | TAOK1 | 0.61040778 |
| 116 | DYRK1B | 0.60887770 |
| 117 | IKBKE | 0.60034004 |
| 118 | TNK2 | 0.59785624 |
| 119 | HIPK2 | 0.59608365 |
| 120 | TRPM7 | 0.59259601 |
| 121 | PDGFRB | 0.58486073 |
| 122 | ITK | 0.58024829 |
| 123 | WNK4 | 0.57886551 |
| 124 | CAMK2A | 0.56658867 |
| 125 | PRKCH | 0.56386252 |
| 126 | JAK1 | 0.56292702 |
| 127 | PRKG1 | 0.56109864 |
| 128 | TGFBR2 | 0.55305781 |
| 129 | SYK | 0.55268827 |
| 130 | ILK | 0.54251747 |
| 131 | PRKCE | 0.54241892 |
| 132 | MTOR | 0.53538264 |
| 133 | CDK7 | 0.52495590 |
| 134 | ZAP70 | 0.52111477 |
| 135 | LRRK2 | 0.51896651 |
| 136 | IRAK3 | 0.51700005 |
| 137 | TNIK | 0.51102421 |
| 138 | BRD4 | 0.50980664 |
| 139 | FGFR3 | 0.49844191 |
| 140 | CAMK4 | 0.49319435 |
| 141 | JAK3 | 0.47723325 |
| 142 | TGFBR1 | 0.46970034 |
| 143 | MAP2K4 | 0.46897080 |
| 144 | BMPR2 | 0.46250616 |
| 145 | PRKD1 | 0.45803306 |
| 146 | CDK3 | 0.45346399 |
| 147 | MARK3 | 0.45311461 |
| 148 | CDK12 | 0.44829984 |
| 149 | WNK1 | 0.44336423 |
| 150 | MAPKAPK5 | 0.44270376 |
| 151 | CDK19 | 0.44173846 |
| 152 | CAMKK1 | 0.44006434 |
| 153 | RPS6KA6 | 0.43952430 |
| 154 | MAP3K13 | 0.43481205 |
| 155 | MAPK4 | 0.42624777 |
| 156 | BMX | 0.42359293 |
| 157 | SGK223 | 0.41976385 |
| 158 | SGK494 | 0.41976385 |
| 159 | RPS6KC1 | 0.40832231 |
| 160 | RPS6KL1 | 0.40832231 |
| 161 | JAK2 | 0.40271144 |
| 162 | PRKACA | 0.39931755 |
| 163 | MAPK3 | 0.38205074 |
| 164 | RPS6KA2 | 0.36952746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.02964439 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.86412325 |
| 3 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.76275795 |
| 4 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.72742937 |
| 5 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.34890254 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.21962370 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.95333161 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.55069106 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27062834 |
| 10 | * Glutathione metabolism_Homo sapiens_hsa00480 | 2.15210859 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14971847 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98954034 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.95245255 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92844989 |
| 15 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.90793896 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.88720054 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82062393 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.80408174 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79004218 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77958084 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.76165626 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75829033 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.75689458 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72886399 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72416966 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.71608634 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68477031 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67016272 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63821460 |
| 30 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.62682241 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61741184 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47662721 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44656446 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.44326667 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.41590463 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39258493 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.38787767 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36568413 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36369515 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.34485606 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.33191116 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31956633 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29807199 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.29171951 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26565098 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.26552101 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25706066 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24165425 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20973831 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20822721 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18138761 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17321197 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 1.16345106 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16198650 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.16186450 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.13685590 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12070605 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08483616 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08314681 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.07097163 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06066867 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02737572 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01579503 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 1.01565749 |
| 65 | Asthma_Homo sapiens_hsa05310 | 1.01120818 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00410511 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98188729 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96321177 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.96156211 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95285908 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89277845 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89084094 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.88695804 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88367688 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88203652 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88199290 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88125757 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.88098976 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87556221 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84985189 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83778477 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82870358 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82785883 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82436641 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.81685693 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80017403 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79302423 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77498956 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77478304 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76725736 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75890587 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75572947 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75465572 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75126758 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.74826630 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74237569 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71683197 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69967770 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67050785 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.66281146 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65586208 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63152857 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62392396 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61750747 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59841329 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58811829 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58723413 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58338284 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57514354 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.57480734 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54746868 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53708732 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52846128 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52754648 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52215967 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51942517 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51931642 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50750159 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49705198 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49475672 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49350866 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49186467 |
| 123 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48506590 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.48090916 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47716161 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47213666 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45685847 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.45407134 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44543701 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44497605 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43774125 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.43650421 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.42088022 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39719355 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39158807 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38518794 |
| 137 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38160041 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.36459979 |
| 139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34319883 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.28793914 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28110686 |
| 142 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27998321 |
| 143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27857916 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27623978 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25859946 |
| 146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25236088 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24489334 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23416161 |
| 149 | Prostate cancer_Homo sapiens_hsa05215 | 0.23207225 |
| 150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21965966 |
| 151 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21958232 |
| 152 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20640442 |
| 153 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19994528 |
| 154 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19992086 |
| 155 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18599440 |
| 156 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17362806 |
| 157 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17074106 |
| 158 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15609576 |
| 159 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.14882826 |
| 160 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.14414292 |

